Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Angioplasty Balloons Market Analysis

ID: MRFR/HC/8136-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Angioplasty Balloons Market Research Report: Size, Share, Trend Analysis By Types (Drug-Eluting Balloons, Plain Old Balloons, Scoring Balloons), By Applications (Coronary Angioplasty, Peripheral Angioplasty, Renal Angioplasty), By Material (Polymer, Latex, Metal), By End Use (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Angioplasty Balloons Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Methodology Download PDF

Market Analysis

In-depth Analysis of Angioplasty Balloons Market Industry Landscape

Market dynamics are strongly influenced by the high incidence of cardiovascular diseases globally. As conditions such as coronary artery disease become more prevalent, the demand for angioplasty balloons as a key tool in percutaneous coronary interventions (PCI) is rising. Innovative technological developments in the springing up of angioplasty balloon design also contribute a major part to market dynamics. The focus of engineering advancements is made regarding flexibility, trackability, and inflation characteristics in which physicians can navigate complex anatomy and maximize balloon capacity during procedures. Currently, the market is experiencing an unusual trend – wider use of drug-eluting balloons in preventing restenosis. These balloons are covered with antiproliferative agents, preventing regrowth of cells and hoping that these kept on receding, which would increase the longevity of angioplasty success. Changes occurring in the market are caused by the ageing of mankind, as it is more likely for elderly to be affected by heart diseases. Angioplasty involved balloon holding a significant importance in the discussion of vascular conditions situation which is present in geriatric group. The demand for minimally invasive procedures has increased as this makes it easier to stimulate market growth. The less invasive approach that offers more recovery times, hospital stays and overall distress, first by means of angioplasty. Increasingly PCI becomes a relevant strategy for heart health care systems. In the emerging economies, where healthcare infrastructure is on the rise, there lies a growing requirement for angioplasty balloons market. Improved access to sophisticated medical treatments as well as better awareness of cardiovascular health all these along with other factors are leading the adoption angioplasty balloons in a rising trend for this regions. The patient security and outcomes are some of the areas aligning to these market dynamics as there is more concentration emphasized on these. Innovations related to angioplasty balloons, in turn, serve the purpose of reducing proceduredale complications in addition to making it more accurate and favorable for the patients after a postangioplasty procedure. The market nature is aggressive with significant players in their actions showing strategic array. The innovations of angioplasty balloon technologies and procedures are due to the cooperating ventures among medical device companies, research facilities, and health institutions. The cost-based and fiscal considerations form a rich mix of the macro factors which create market dynamics in the healthcare budgets. One aspect of interest in analyzing market trends is balanced efficiency with angioplasty procedures and economy-related availability of angioplasty balloons in various health care settings to diverse audiences. The production and authorizations to use angioplasty balloons are open to stringent regulatory standards. Adherence to such rules is vital for market players usages to guarantee the safety, effectiveness and standards of angioplasty devices which may assisted in creating reliability between award UI staff and regulatory affairs. The angioplasty balloons market is poised for continued growth as cardiovascular diseases remain a leading cause of morbidity and mortality worldwide. Future trends may include further advancements in balloon technologies, a focus on personalized medicine, and ongoing efforts to enhance the accessibility and cost-effectiveness of angioplasty procedures, ultimately improving patient outcomes in cardiovascular care.

Author
Author Profile
Rahul Gotadki
Research Manager

He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Get In Touch

Leave a Comment

FAQs

What is the projected market valuation of the Angioplasty Balloons Market by 2035?

<p>The projected market valuation of the Angioplasty Balloons Market is expected to reach 5.1 USD Billion by 2035.</p>

What was the overall market valuation of the Angioplasty Balloons Market in 2024?

<p>The overall market valuation of the Angioplasty Balloons Market was 3.38 USD Billion in 2024.</p>

What is the expected CAGR for the Angioplasty Balloons Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Angioplasty Balloons Market during the forecast period 2025 - 2035 is 3.81%.</p>

Which segment is projected to have the highest valuation in the Angioplasty Balloons Market by 2035?

<p>The Drug-Eluting Balloons segment is projected to reach a valuation of 2.0 USD Billion by 2035.</p>

What are the key applications of angioplasty balloons in the market?

<p>The key applications include Coronary Angioplasty, Peripheral Angioplasty, and Renal Angioplasty, with Coronary Angioplasty projected to reach 2.45 USD Billion by 2035.</p>

Which materials are predominantly used in the production of angioplasty balloons?

<p>The predominant materials include Polymer, Latex, and Metal, with Polymer expected to reach 2.0 USD Billion by 2035.</p>

What is the expected valuation of the Ambulatory Surgical Centers segment by 2035?

<p>The Ambulatory Surgical Centers segment is expected to reach a valuation of 1.25 USD Billion by 2035.</p>

Who are the leading players in the Angioplasty Balloons Market?

<p>The leading players in the Angioplasty Balloons Market include Boston Scientific, Medtronic, and Abbott Laboratories.</p>

What was the valuation of the Scoring Balloons segment in 2024?

<p>The Scoring Balloons segment was valued at 1.03 USD Billion in 2024.</p>

How does the market for Plain Old Balloons compare to Drug-Eluting Balloons by 2035?

<p>By 2035, the Plain Old Balloons segment is projected to reach 1.5 USD Billion, while Drug-Eluting Balloons is expected to reach 2.0 USD Billion.</p>

Market Summary

As per Market Research Future analysis, the Angioplasty Balloons Market Size was estimated at 3.38 USD Billion in 2024. The Angioplasty Balloons industry is projected to grow from 3.509 USD Billion in 2025 to 5.1 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 3.81% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Angioplasty Balloons Market is poised for growth driven by technological advancements and increasing healthcare investments.

  • North America remains the largest market for angioplasty balloons, reflecting a robust healthcare infrastructure. Asia-Pacific is emerging as the fastest-growing region, fueled by rising healthcare expenditures and population awareness. Drug-eluting balloons dominate the market, while scoring balloons are witnessing rapid growth due to their innovative designs. Technological advancements and the rising prevalence of cardiovascular diseases are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 3.38 (USD Billion)
2035 Market Size 5.1 (USD Billion)
CAGR (2025 - 2035) 3.81%
Largest Regional Market Share in 2024 North America

Major Players

<p>Boston Scientific (US), <a href="https://www.medtronic.com/in-en/healthcare-professionals/products.html">Medtronic </a>(US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Cordis (US), Terumo Corporation (JP), Asahi Intecc Co., Ltd. (JP), Cook Medical (US), AngioDynamics (US)</p>

Market Trends

The Angioplasty Balloons Market is currently experiencing a notable evolution, driven by advancements in medical technology and an increasing prevalence of cardiovascular diseases. The demand for minimally invasive procedures has surged, as healthcare providers and patients alike seek alternatives to traditional surgical methods. This shift is fostering innovation in balloon designs, materials, and delivery systems, which are becoming more sophisticated and tailored to specific patient needs. Furthermore, the growing awareness of preventive healthcare is prompting more individuals to seek early intervention, thereby expanding the market's reach and potential. In addition, regulatory bodies are playing a crucial role in shaping the landscape of the Angioplasty Balloons Market. Stricter guidelines and quality standards are being implemented to ensure patient safety and efficacy of devices. This regulatory environment, while challenging, is likely to encourage manufacturers to invest in research and development, leading to the introduction of novel products. As the market continues to mature, collaboration between industry stakeholders, including healthcare providers, angioplasty balloon manufacturers, and regulatory agencies, appears essential for fostering innovation and improving patient outcomes..

Technological Advancements

The Angioplasty Balloons Market is witnessing rapid technological advancements, particularly in balloon design and materials. Innovations such as drug-eluting balloons and bioresorbable materials are enhancing the effectiveness of procedures, potentially leading to better patient outcomes. These developments may also contribute to reduced recovery times and lower complication rates.

Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases is significantly influencing the Angioplasty Balloons Market. As more individuals are diagnosed with conditions requiring angioplasty, the demand for effective treatment options is likely to rise. This trend underscores the importance of timely interventions and the need for advanced medical devices.

Regulatory Influence

Regulatory bodies are becoming increasingly influential in the Angioplasty Balloons Market. Stricter regulations and quality standards are being established to ensure the safety and efficacy of medical devices. While this may pose challenges for angioplasty balloon manufacturers, it also encourages innovation and the development of higher-quality products.

Angioplasty Balloons Market Market Drivers

Regulatory Influence on Market Dynamics

Regulatory frameworks play a crucial role in shaping the Angioplasty Balloons Market. Stringent regulations ensure the safety and efficacy of medical devices, including angioplasty balloons. Compliance with these regulations can be a double-edged sword; while they may pose challenges for manufacturers, they also foster innovation and quality improvements. Regulatory bodies are increasingly focusing on post-market surveillance and real-world evidence, which can influence product development and market entry strategies. As companies navigate these regulatory landscapes, the Angioplasty Balloons Market is likely to evolve, with an emphasis on transparency and patient safety. This dynamic environment may lead to the introduction of new products that meet regulatory standards.

Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases is a primary driver for the Angioplasty Balloons Market. As populations age and lifestyle-related health issues become more prevalent, the demand for effective treatment options rises. Statistics indicate that cardiovascular diseases remain a leading cause of mortality worldwide, prompting healthcare systems to seek innovative solutions. Angioplasty procedures, facilitated by advanced balloon technologies, are becoming a standard treatment for conditions such as coronary artery disease. This growing patient population necessitates a robust supply of angioplasty balloons, thereby propelling market growth. The Angioplasty Balloons Market is thus positioned to expand as healthcare providers respond to this urgent need.

Growing Investment in Healthcare Infrastructure

Investment in healthcare infrastructure is a significant driver for the Angioplasty Balloons Market. As countries prioritize healthcare improvements, the establishment of advanced medical facilities and the procurement of cutting-edge medical devices become essential. Increased funding for cardiovascular care, particularly in emerging markets, is expected to enhance access to angioplasty procedures. This trend is supported by government initiatives aimed at reducing the burden of cardiovascular diseases. Consequently, the demand for angioplasty balloons is anticipated to rise, as healthcare providers seek to equip their facilities with the latest technologies. The Angioplasty Balloons Market stands to benefit from this influx of investment, potentially leading to enhanced patient care.

Technological Advancements in Angioplasty Balloons

The Angioplasty Balloons Market is experiencing a notable transformation due to rapid technological advancements. Innovations such as drug-eluting balloons and bioresorbable materials are enhancing the efficacy of angioplasty procedures. These advancements not only improve patient outcomes but also reduce the risk of restenosis, a common complication. The introduction of advanced imaging techniques and minimally invasive procedures is further driving the adoption of angioplasty balloons. According to recent data, the market for drug-eluting balloons is projected to grow significantly, indicating a shift towards more effective treatment options. As healthcare providers increasingly adopt these technologies, the Angioplasty Balloons Market is likely to witness substantial growth in the coming years.

Increasing Awareness and Education on Cardiovascular Health

The growing awareness and education surrounding cardiovascular health are pivotal for the Angioplasty Balloons Market. Public health campaigns and educational initiatives are informing populations about the risks associated with cardiovascular diseases and the importance of early intervention. As individuals become more knowledgeable about treatment options, including angioplasty, the demand for these procedures is likely to increase. Healthcare providers are also focusing on patient education, which can lead to higher rates of diagnosis and treatment. This heightened awareness is expected to drive the adoption of angioplasty balloons, as patients seek effective solutions for their cardiovascular issues. The Angioplasty Balloons Market is thus poised for growth as awareness continues to expand.

Market Segment Insights

By Type: Drug-Eluting Balloons (Largest) vs. Scoring Balloons (Fastest-Growing)

<p>In the Angioplasty Balloons Market, Drug-Eluting Balloons, which is one of the crucial angioplasty balloon types, command a significant share due to their ability to deliver medication directly to the affected area, thereby reducing the risk of restenosis. Plain Old Balloons, while being a standard choice, cater to a specific segment of patients who may not require advanced therapy. Scoring Balloons are gradually carving out their niche with their ability to provide enhanced vessel modifications, thus complementing the existing offerings in this market.</p>

<p>Drug-Eluting Balloons (Dominant) vs. Scoring Balloons (Emerging)</p>

<p>Drug-Eluting Balloons hold a dominant position in the <a href="https://www.marketresearchfuture.com/reports/angioplasty-balloons-market-9614">Angioplasty </a>Balloons Market due to their unique design that combines angioplasty with localized drug therapy. This has proven effective in reducing restenosis rates, making them a preferred choice among cardiologists. In contrast, Scoring Balloons are an emerging solution that provides mechanical help to opened vessels and encourage positive remodeling of the arteries. Their growth is driven by increasing procedural volume and the need for innovative technologies that ensure patient safety and efficacy, positioning them as a promising alternative to traditional options.</p>

By Application: Coronary Angioplasty (Largest) vs. Peripheral Angioplasty (Fastest-Growing)

<p>In the Angioplasty Balloons Market, the application segment is prominently dominated by coronary angioplasty. This segment holds the majority market share due to the high prevalence of coronary artery diseases and the increasing number of angioplasty procedures globally. Peripheral angioplasty follows closely, showing significant growth as healthcare providers focus on treating peripheral artery diseases, which have become increasingly recognized and treated in recent years.</p>

<p>Coronary Angioplasty (Dominant) vs. Peripheral Angioplasty (Emerging)</p>

<p>Coronary angioplasty remains the dominant segment in the Angioplasty Balloons Market, primarily because of its established use and effectiveness in treating coronary artery blockages. It is widely favored among healthcare professionals and patients for its proven success rates. On the other hand, peripheral angioplasty is an emerging segment that has gained traction due to the rising incidence of peripheral artery disease (PAD). This segment is expected to witness robust growth driven by advancements in balloon technology and increasing awareness about the treatment options available for chronic limb ischemia. The increasing patient population and the need for minimally invasive procedures further support the expansion of this segment.</p>

By Material: Polymer (Largest) vs. Metal (Fastest-Growing)

<p>In the Angioplasty Balloons Market, the angioplasty balloon material segment showcases a diverse range of options, with polymers leading the share distribution. Polymeric balloons are favored for their flexibility and compliance, making them ideal for various angioplasty procedures. They account for a significant portion of market usage, offering a superior balance of performance and patient safety. On the other hand, metal balloons, although smaller in market share, are gaining traction due to their robustness and ability to maintain shape under high-pressure conditions, making them suitable for specific clinical applications. The growth trends indicate a pronounced shift towards polymer materials, driven by technological advancements and increasing demand for minimally invasive procedures. Furthermore, the market for metal balloons is rapidly expanding as they are recognized for their durability and efficacy in challenging anatomical circumstances. As healthcare providers continue to prioritize patient outcomes, the development of advanced polymer formulations and metal balloon designs is expected to accelerate, shaping the competitive landscape of the Angioplasty Balloons Market.Regional Insights</p>

<p>Polymer (Dominant) vs. Metal (Emerging)</p>

<p>Polymer balloons dominate the Angioplasty Balloons Market due to their excellent performance characteristics, including flexibility, compliance, and safety. These attributes enable them to effectively navigate the vascular system while minimizing the risk of vessel trauma. Their adaptability to various angioplasty techniques makes them the preferred choice among healthcare professionals. In contrast, metal balloons represent an emerging segment, characterized by their strength and ability to withstand high pressures. Although they have a smaller market presence, their unique properties are leading to increased adoption in certain scenarios, particularly where durability is essential. The distinction between these materials is critical, as they cater to different clinical needs and influence procedural outcomes.</p>

By End Use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

<p>In the Angioplasty Balloons Market, hospitals represent the largest end-use segment, catering to a significant share of procedures due to their comprehensive facilities and specialized staffing. Ambulatory Surgical Centers (ASCs), although smaller in market share compared to hospitals, are quickly gaining traction, attributed to their efficiency and cost-effectiveness. The growth trends within this segment indicate a strong inclination towards minimally invasive procedures conducted in ASCs, which are seen as a more patient-centric approach. The increasing preference for outpatient services and technological advancements, such as improved balloon designs, are key factors driving the expansion of ASCs in the market.</p>

<p>Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)</p>

<p>Hospitals continue to dominate the Angioplasty Balloons Market due to their extensive infrastructure, broader range of services, and 24/7 availability of healthcare professionals. They are well-equipped to handle complex cases and offer comprehensive post-procedure care, making them a preferred choice for critical interventions. On the other hand, Ambulatory Surgical Centers are emerging as a popular alternative owing to their focus on outpatient care, lower costs, and increased patient convenience. ASCs leverage advancements in medical technology and a streamlined approach to procedures, which appeals to a growing patient base opting for less invasive surgical options. This shift in preferences is reshaping the landscape of the angioplasty balloons market.</p>

Get more detailed insights about Angioplasty Balloons Market Research Report - Forecast till 2035

Regional Insights

North America : Healthcare Innovation Leader.

North America is the largest market for angioplasty balloons, holding approximately 45% of the global market share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and a strong focus on innovation. Regulatory support from agencies like the FDA facilitates rapid product approvals, enhancing market dynamics. The demand for minimally invasive procedures is also on the rise, further propelling market growth. The United States is the leading country in this region, with major players such as Boston Scientific, Medtronic, and Abbott Laboratories dominating the landscape via Abbott balloons. The competitive environment is characterized by continuous innovation and strategic partnerships among key players. Canada also contributes significantly to the market, focusing on improving healthcare access and patient outcomes, thereby supporting the overall growth of the cardiac balloons market.

Europe : Emerging Regulatory Frameworks

Europe is the second-largest market for cardiac balloons, accounting for approximately 30% of the global market share. The region benefits from a robust healthcare system and increasing investments in medical technology. Regulatory frameworks, such as the Medical Device Regulation (MDR), are evolving to ensure patient safety and product efficacy, which in turn drives market growth. The rising incidence of cardiovascular diseases and an aging population further fuel demand for angioplasty procedures. Leading countries in Europe include Germany, France, and the UK, where key players like B. Braun Melsungen AG and Cordis are actively involved. The competitive landscape is marked by innovation and collaboration among manufacturers to enhance product offerings. The presence of advanced research institutions also supports the development of cutting-edge technologies in the cardiac balloons market.

Asia-Pacific : Rapidly Growing Market

Asia-Pacific is witnessing rapid growth in the angioplasty balloons market, driven by increasing healthcare expenditure and a rising prevalence of cardiovascular diseases. The region holds approximately 20% of the global market share, with countries like Japan and China leading the charge. Government initiatives aimed at improving healthcare infrastructure and access to advanced medical technologies are significant growth drivers. The demand for minimally invasive procedures is also on the rise, contributing to market expansion. Japan is a key player in this market, with companies like Terumo Corporation and Asahi Intecc Co., Ltd. leading the way. The competitive landscape is characterized by a mix of local and international players, fostering innovation and collaboration. Additionally, the growing awareness of cardiovascular health among the population is expected to further boost the demand for angioplasty balloons in the region.

Middle East and Africa : Untapped Market Potential

The Middle East and Africa region is gradually emerging as a potential market for angioplasty balloons, holding approximately 5% of the global market share. The growth is driven by increasing healthcare investments and a rising prevalence of cardiovascular diseases. Governments are focusing on enhancing healthcare infrastructure and access to advanced medical technologies, which are crucial for market development. The demand for angioplasty procedures is expected to rise as awareness of cardiovascular health improves. Leading countries in this region include South Africa and the UAE, where healthcare reforms are paving the way for advanced medical solutions. The competitive landscape is still developing, with opportunities for both local and international players to enter the market. Key players are beginning to explore partnerships and collaborations to expand their reach in this untapped market.

Key Players and Competitive Insights

The Angioplasty Balloons Market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Major players such as Boston Scientific (US), Medtronic (US), and Abbott Laboratories (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market positions. Boston Scientific (US) emphasizes the development of advanced balloon technologies, while Medtronic (US) is leveraging its extensive distribution network to penetrate emerging markets. Abbott Laboratories (US) appears to be concentrating on expanding its product portfolio through acquisitions, thereby enhancing its competitive edge in this rapidly evolving sector. In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market structure is moderately fragmented, with several key players exerting considerable influence. This fragmentation allows for a diverse range of products and innovations, fostering a competitive environment where companies must continuously adapt to maintain their market share. In August 2025, Boston Scientific (US) announced the launch of its latest drug-coated balloon, which is designed to improve patient outcomes in complex coronary interventions. This strategic move not only reinforces Boston Scientific's commitment to innovation but also positions the company to capture a larger share of the growing market for advanced angioplasty solutions. The introduction of this product is expected to enhance procedural efficiency and patient safety, thereby solidifying the company's reputation as a leader in the field. In September 2025, Medtronic (US) entered into a strategic partnership with a leading telehealth provider to integrate remote monitoring capabilities into its angioplasty balloon offerings. This collaboration aims to enhance patient engagement and streamline post-procedural care, reflecting a broader trend towards digital health solutions. By incorporating telehealth features, Medtronic (US) is likely to improve patient outcomes and satisfaction, which could translate into increased market share in the competitive landscape. In July 2025, Abbott Laboratories (US) completed the acquisition of a smaller medical device company specializing in innovative balloon technologies. This acquisition is indicative of Abbott's strategy to bolster its product offerings and expand its technological capabilities. By integrating these new technologies, Abbott Laboratories (US) is poised to enhance its competitive positioning and respond more effectively to the evolving needs of healthcare providers and patients. As of October 2025, the Angioplasty Balloons Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence in product development. Strategic alliances are becoming increasingly important, as companies seek to leverage complementary strengths to drive innovation. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, supply chain reliability, and enhanced patient outcomes. This shift underscores the necessity for companies to invest in research and development to stay ahead in a market that is rapidly changing.

Key Companies in the Angioplasty Balloons Market include

Industry Developments

Recent developments in the Angioplasty Balloons Market indicate a significant increase in demand driven by the rise in cardiovascular diseases globally.

Companies like Medtronic Cardiovascular and Boston Scientific have been focusing on enhancing their product offerings to include advanced balloon technologies that improve patient outcomes.

Notably, in September 2023, Abbott Laboratories announced the launch of a new line of drug-eluting balloons, aimed at providing more effective treatment options for patients suffering from coronary artery disease.

Furthermore, a strategic merger was confirmed in August 2023, where Philips Healthcare acquired a small biotechnology firm specializing in innovative angioplasty balloon technologies, thereby augmenting its portfolio.

Meanwhile, Asahi Intecc reported a steady growth in market valuation due to the increasing adoption of minimally invasive procedures, reflecting a broader industry trend aligning with healthcare advancements.

In recent years, significant investments led by Johnson and Johnson and Cook Medical into Research and Development activities have aimed to drive innovation in angioplasty balloon designs, contributing to the overall market growth.

These advancements and corporate strategies highlight the evolving landscape of the Angioplasty Balloons Market as companies look to capture market share through technological improvements and strategic collaborations.

 

Future Outlook

Angioplasty Balloons Market Future Outlook

<p>The Angioplasty Balloons Market is projected to grow at a 3.81% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures.</p>

New opportunities lie in:

  • <p>Development of biodegradable angioplasty balloons for enhanced patient safety. Expansion into emerging markets with tailored product offerings. Integration of smart technology for real-time monitoring during procedures.</p>

<p>By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.</p>

Market Segmentation

Angioplasty Balloons Market Type Outlook

  • Drug-Eluting Balloons
  • Plain Old Balloons
  • Scoring Balloons

Angioplasty Balloons Market End Use Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories

Angioplasty Balloons Market Material Outlook

  • Polymer
  • Latex
  • Metal

Angioplasty Balloons Market Application Outlook

  • Coronary Angioplasty
  • Peripheral Angioplasty
  • Renal Angioplasty

Report Scope

MARKET SIZE 2024 3.38(USD Billion)
MARKET SIZE 2025 3.509(USD Billion)
MARKET SIZE 2035 5.1(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 3.81% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Boston Scientific (US), Medtronic (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Cordis (US), Terumo Corporation (JP), Asahi Intecc Co., Ltd. (JP), Cook Medical (US), AngioDynamics (US)
Segments Covered Types, Applications, Material, End Use, Regional
Key Market Opportunities Advancements in biodegradable materials enhance safety and efficacy in the Angioplasty Balloons Market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the angioplasty balloons market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Angioplasty Balloons Market by 2035?

<p>The projected market valuation of the Angioplasty Balloons Market is expected to reach 5.1 USD Billion by 2035.</p>

What was the overall market valuation of the Angioplasty Balloons Market in 2024?

<p>The overall market valuation of the Angioplasty Balloons Market was 3.38 USD Billion in 2024.</p>

What is the expected CAGR for the Angioplasty Balloons Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Angioplasty Balloons Market during the forecast period 2025 - 2035 is 3.81%.</p>

Which segment is projected to have the highest valuation in the Angioplasty Balloons Market by 2035?

<p>The Drug-Eluting Balloons segment is projected to reach a valuation of 2.0 USD Billion by 2035.</p>

What are the key applications of angioplasty balloons in the market?

<p>The key applications include Coronary Angioplasty, Peripheral Angioplasty, and Renal Angioplasty, with Coronary Angioplasty projected to reach 2.45 USD Billion by 2035.</p>

Which materials are predominantly used in the production of angioplasty balloons?

<p>The predominant materials include Polymer, Latex, and Metal, with Polymer expected to reach 2.0 USD Billion by 2035.</p>

What is the expected valuation of the Ambulatory Surgical Centers segment by 2035?

<p>The Ambulatory Surgical Centers segment is expected to reach a valuation of 1.25 USD Billion by 2035.</p>

Who are the leading players in the Angioplasty Balloons Market?

<p>The leading players in the Angioplasty Balloons Market include Boston Scientific, Medtronic, and Abbott Laboratories.</p>

What was the valuation of the Scoring Balloons segment in 2024?

<p>The Scoring Balloons segment was valued at 1.03 USD Billion in 2024.</p>

How does the market for Plain Old Balloons compare to Drug-Eluting Balloons by 2035?

<p>By 2035, the Plain Old Balloons segment is projected to reach 1.5 USD Billion, while Drug-Eluting Balloons is expected to reach 2.0 USD Billion.</p>

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Type (USD Billion)
    2. | | 4.1.1 Drug-Eluting Balloons
    3. | | 4.1.2 Plain Old Balloons
    4. | | 4.1.3 Scoring Balloons
    5. | 4.2 Healthcare, BY Application (USD Billion)
    6. | | 4.2.1 Coronary Angioplasty
    7. | | 4.2.2 Peripheral Angioplasty
    8. | | 4.2.3 Renal Angioplasty
    9. | 4.3 Healthcare, BY Material (USD Billion)
    10. | | 4.3.1 Polymer
    11. | | 4.3.2 Latex
    12. | | 4.3.3 Metal
    13. | 4.4 Healthcare, BY End Use (USD Billion)
    14. | | 4.4.1 Hospitals
    15. | | 4.4.2 Ambulatory Surgical Centers
    16. | | 4.4.3 Cardiac Catheterization Laboratories
    17. | 4.5 Healthcare, BY Region (USD Billion)
    18. | | 4.5.1 North America
    19. | | | 4.5.1.1 US
    20. | | | 4.5.1.2 Canada
    21. | | 4.5.2 Europe
    22. | | | 4.5.2.1 Germany
    23. | | | 4.5.2.2 UK
    24. | | | 4.5.2.3 France
    25. | | | 4.5.2.4 Russia
    26. | | | 4.5.2.5 Italy
    27. | | | 4.5.2.6 Spain
    28. | | | 4.5.2.7 Rest of Europe
    29. | | 4.5.3 APAC
    30. | | | 4.5.3.1 China
    31. | | | 4.5.3.2 India
    32. | | | 4.5.3.3 Japan
    33. | | | 4.5.3.4 South Korea
    34. | | | 4.5.3.5 Malaysia
    35. | | | 4.5.3.6 Thailand
    36. | | | 4.5.3.7 Indonesia
    37. | | | 4.5.3.8 Rest of APAC
    38. | | 4.5.4 South America
    39. | | | 4.5.4.1 Brazil
    40. | | | 4.5.4.2 Mexico
    41. | | | 4.5.4.3 Argentina
    42. | | | 4.5.4.4 Rest of South America
    43. | | 4.5.5 MEA
    44. | | | 4.5.5.1 GCC Countries
    45. | | | 4.5.5.2 South Africa
    46. | | | 4.5.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Boston Scientific (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Medtronic (US)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Abbott Laboratories (US)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 B. Braun Melsungen AG (DE)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Cordis (US)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Terumo Corporation (JP)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Asahi Intecc Co., Ltd. (JP)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Cook Medical (US)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | | 5.2.9 AngioDynamics (US)
    65. | | | 5.2.9.1 Financial Overview
    66. | | | 5.2.9.2 Products Offered
    67. | | | 5.2.9.3 Key Developments
    68. | | | 5.2.9.4 SWOT Analysis
    69. | | | 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | | 5.3.1 References
    72. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY TYPE
    4. | 6.4 US MARKET ANALYSIS BY APPLICATION
    5. | 6.5 US MARKET ANALYSIS BY MATERIAL
    6. | 6.6 US MARKET ANALYSIS BY END USE
    7. | 6.7 CANADA MARKET ANALYSIS BY TYPE
    8. | 6.8 CANADA MARKET ANALYSIS BY APPLICATION
    9. | 6.9 CANADA MARKET ANALYSIS BY MATERIAL
    10. | 6.10 CANADA MARKET ANALYSIS BY END USE
    11. | 6.11 EUROPE MARKET ANALYSIS
    12. | 6.12 GERMANY MARKET ANALYSIS BY TYPE
    13. | 6.13 GERMANY MARKET ANALYSIS BY APPLICATION
    14. | 6.14 GERMANY MARKET ANALYSIS BY MATERIAL
    15. | 6.15 GERMANY MARKET ANALYSIS BY END USE
    16. | 6.16 UK MARKET ANALYSIS BY TYPE
    17. | 6.17 UK MARKET ANALYSIS BY APPLICATION
    18. | 6.18 UK MARKET ANALYSIS BY MATERIAL
    19. | 6.19 UK MARKET ANALYSIS BY END USE
    20. | 6.20 FRANCE MARKET ANALYSIS BY TYPE
    21. | 6.21 FRANCE MARKET ANALYSIS BY APPLICATION
    22. | 6.22 FRANCE MARKET ANALYSIS BY MATERIAL
    23. | 6.23 FRANCE MARKET ANALYSIS BY END USE
    24. | 6.24 RUSSIA MARKET ANALYSIS BY TYPE
    25. | 6.25 RUSSIA MARKET ANALYSIS BY APPLICATION
    26. | 6.26 RUSSIA MARKET ANALYSIS BY MATERIAL
    27. | 6.27 RUSSIA MARKET ANALYSIS BY END USE
    28. | 6.28 ITALY MARKET ANALYSIS BY TYPE
    29. | 6.29 ITALY MARKET ANALYSIS BY APPLICATION
    30. | 6.30 ITALY MARKET ANALYSIS BY MATERIAL
    31. | 6.31 ITALY MARKET ANALYSIS BY END USE
    32. | 6.32 SPAIN MARKET ANALYSIS BY TYPE
    33. | 6.33 SPAIN MARKET ANALYSIS BY APPLICATION
    34. | 6.34 SPAIN MARKET ANALYSIS BY MATERIAL
    35. | 6.35 SPAIN MARKET ANALYSIS BY END USE
    36. | 6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE
    37. | 6.37 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    38. | 6.38 REST OF EUROPE MARKET ANALYSIS BY MATERIAL
    39. | 6.39 REST OF EUROPE MARKET ANALYSIS BY END USE
    40. | 6.40 APAC MARKET ANALYSIS
    41. | 6.41 CHINA MARKET ANALYSIS BY TYPE
    42. | 6.42 CHINA MARKET ANALYSIS BY APPLICATION
    43. | 6.43 CHINA MARKET ANALYSIS BY MATERIAL
    44. | 6.44 CHINA MARKET ANALYSIS BY END USE
    45. | 6.45 INDIA MARKET ANALYSIS BY TYPE
    46. | 6.46 INDIA MARKET ANALYSIS BY APPLICATION
    47. | 6.47 INDIA MARKET ANALYSIS BY MATERIAL
    48. | 6.48 INDIA MARKET ANALYSIS BY END USE
    49. | 6.49 JAPAN MARKET ANALYSIS BY TYPE
    50. | 6.50 JAPAN MARKET ANALYSIS BY APPLICATION
    51. | 6.51 JAPAN MARKET ANALYSIS BY MATERIAL
    52. | 6.52 JAPAN MARKET ANALYSIS BY END USE
    53. | 6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE
    54. | 6.54 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    55. | 6.55 SOUTH KOREA MARKET ANALYSIS BY MATERIAL
    56. | 6.56 SOUTH KOREA MARKET ANALYSIS BY END USE
    57. | 6.57 MALAYSIA MARKET ANALYSIS BY TYPE
    58. | 6.58 MALAYSIA MARKET ANALYSIS BY APPLICATION
    59. | 6.59 MALAYSIA MARKET ANALYSIS BY MATERIAL
    60. | 6.60 MALAYSIA MARKET ANALYSIS BY END USE
    61. | 6.61 THAILAND MARKET ANALYSIS BY TYPE
    62. | 6.62 THAILAND MARKET ANALYSIS BY APPLICATION
    63. | 6.63 THAILAND MARKET ANALYSIS BY MATERIAL
    64. | 6.64 THAILAND MARKET ANALYSIS BY END USE
    65. | 6.65 INDONESIA MARKET ANALYSIS BY TYPE
    66. | 6.66 INDONESIA MARKET ANALYSIS BY APPLICATION
    67. | 6.67 INDONESIA MARKET ANALYSIS BY MATERIAL
    68. | 6.68 INDONESIA MARKET ANALYSIS BY END USE
    69. | 6.69 REST OF APAC MARKET ANALYSIS BY TYPE
    70. | 6.70 REST OF APAC MARKET ANALYSIS BY APPLICATION
    71. | 6.71 REST OF APAC MARKET ANALYSIS BY MATERIAL
    72. | 6.72 REST OF APAC MARKET ANALYSIS BY END USE
    73. | 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. | 6.74 BRAZIL MARKET ANALYSIS BY TYPE
    75. | 6.75 BRAZIL MARKET ANALYSIS BY APPLICATION
    76. | 6.76 BRAZIL MARKET ANALYSIS BY MATERIAL
    77. | 6.77 BRAZIL MARKET ANALYSIS BY END USE
    78. | 6.78 MEXICO MARKET ANALYSIS BY TYPE
    79. | 6.79 MEXICO MARKET ANALYSIS BY APPLICATION
    80. | 6.80 MEXICO MARKET ANALYSIS BY MATERIAL
    81. | 6.81 MEXICO MARKET ANALYSIS BY END USE
    82. | 6.82 ARGENTINA MARKET ANALYSIS BY TYPE
    83. | 6.83 ARGENTINA MARKET ANALYSIS BY APPLICATION
    84. | 6.84 ARGENTINA MARKET ANALYSIS BY MATERIAL
    85. | 6.85 ARGENTINA MARKET ANALYSIS BY END USE
    86. | 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
    87. | 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    88. | 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY MATERIAL
    89. | 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
    90. | 6.90 MEA MARKET ANALYSIS
    91. | 6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE
    92. | 6.92 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    93. | 6.93 GCC COUNTRIES MARKET ANALYSIS BY MATERIAL
    94. | 6.94 GCC COUNTRIES MARKET ANALYSIS BY END USE
    95. | 6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE
    96. | 6.96 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    97. | 6.97 SOUTH AFRICA MARKET ANALYSIS BY MATERIAL
    98. | 6.98 SOUTH AFRICA MARKET ANALYSIS BY END USE
    99. | 6.99 REST OF MEA MARKET ANALYSIS BY TYPE
    100. | 6.100 REST OF MEA MARKET ANALYSIS BY APPLICATION
    101. | 6.101 REST OF MEA MARKET ANALYSIS BY MATERIAL
    102. | 6.102 REST OF MEA MARKET ANALYSIS BY END USE
    103. | 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. | 6.104 RESEARCH PROCESS OF MRFR
    105. | 6.105 DRO ANALYSIS OF HEALTHCARE
    106. | 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. | 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. | 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. | 6.109 HEALTHCARE, BY TYPE, 2024 (% SHARE)
    110. | 6.110 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
    111. | 6.111 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    112. | 6.112 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    113. | 6.113 HEALTHCARE, BY MATERIAL, 2024 (% SHARE)
    114. | 6.114 HEALTHCARE, BY MATERIAL, 2024 TO 2035 (USD Billion)
    115. | 6.115 HEALTHCARE, BY END USE, 2024 (% SHARE)
    116. | 6.116 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
    117. | 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY TYPE, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
    6. | | 7.2.3 BY MATERIAL, 2025-2035 (USD Billion)
    7. | | 7.2.4 BY END USE, 2025-2035 (USD Billion)
    8. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    9. | | 7.3.1 BY TYPE, 2025-2035 (USD Billion)
    10. | | 7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
    11. | | 7.3.3 BY MATERIAL, 2025-2035 (USD Billion)
    12. | | 7.3.4 BY END USE, 2025-2035 (USD Billion)
    13. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    14. | | 7.4.1 BY TYPE, 2025-2035 (USD Billion)
    15. | | 7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
    16. | | 7.4.3 BY MATERIAL, 2025-2035 (USD Billion)
    17. | | 7.4.4 BY END USE, 2025-2035 (USD Billion)
    18. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    19. | | 7.5.1 BY TYPE, 2025-2035 (USD Billion)
    20. | | 7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
    21. | | 7.5.3 BY MATERIAL, 2025-2035 (USD Billion)
    22. | | 7.5.4 BY END USE, 2025-2035 (USD Billion)
    23. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    24. | | 7.6.1 BY TYPE, 2025-2035 (USD Billion)
    25. | | 7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
    26. | | 7.6.3 BY MATERIAL, 2025-2035 (USD Billion)
    27. | | 7.6.4 BY END USE, 2025-2035 (USD Billion)
    28. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    29. | | 7.7.1 BY TYPE, 2025-2035 (USD Billion)
    30. | | 7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
    31. | | 7.7.3 BY MATERIAL, 2025-2035 (USD Billion)
    32. | | 7.7.4 BY END USE, 2025-2035 (USD Billion)
    33. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.8.1 BY TYPE, 2025-2035 (USD Billion)
    35. | | 7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
    36. | | 7.8.3 BY MATERIAL, 2025-2035 (USD Billion)
    37. | | 7.8.4 BY END USE, 2025-2035 (USD Billion)
    38. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    39. | | 7.9.1 BY TYPE, 2025-2035 (USD Billion)
    40. | | 7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
    41. | | 7.9.3 BY MATERIAL, 2025-2035 (USD Billion)
    42. | | 7.9.4 BY END USE, 2025-2035 (USD Billion)
    43. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    44. | | 7.10.1 BY TYPE, 2025-2035 (USD Billion)
    45. | | 7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
    46. | | 7.10.3 BY MATERIAL, 2025-2035 (USD Billion)
    47. | | 7.10.4 BY END USE, 2025-2035 (USD Billion)
    48. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    49. | | 7.11.1 BY TYPE, 2025-2035 (USD Billion)
    50. | | 7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
    51. | | 7.11.3 BY MATERIAL, 2025-2035 (USD Billion)
    52. | | 7.11.4 BY END USE, 2025-2035 (USD Billion)
    53. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    54. | | 7.12.1 BY TYPE, 2025-2035 (USD Billion)
    55. | | 7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
    56. | | 7.12.3 BY MATERIAL, 2025-2035 (USD Billion)
    57. | | 7.12.4 BY END USE, 2025-2035 (USD Billion)
    58. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    59. | | 7.13.1 BY TYPE, 2025-2035 (USD Billion)
    60. | | 7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
    61. | | 7.13.3 BY MATERIAL, 2025-2035 (USD Billion)
    62. | | 7.13.4 BY END USE, 2025-2035 (USD Billion)
    63. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.14.1 BY TYPE, 2025-2035 (USD Billion)
    65. | | 7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
    66. | | 7.14.3 BY MATERIAL, 2025-2035 (USD Billion)
    67. | | 7.14.4 BY END USE, 2025-2035 (USD Billion)
    68. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    69. | | 7.15.1 BY TYPE, 2025-2035 (USD Billion)
    70. | | 7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
    71. | | 7.15.3 BY MATERIAL, 2025-2035 (USD Billion)
    72. | | 7.15.4 BY END USE, 2025-2035 (USD Billion)
    73. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    74. | | 7.16.1 BY TYPE, 2025-2035 (USD Billion)
    75. | | 7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
    76. | | 7.16.3 BY MATERIAL, 2025-2035 (USD Billion)
    77. | | 7.16.4 BY END USE, 2025-2035 (USD Billion)
    78. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    79. | | 7.17.1 BY TYPE, 2025-2035 (USD Billion)
    80. | | 7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
    81. | | 7.17.3 BY MATERIAL, 2025-2035 (USD Billion)
    82. | | 7.17.4 BY END USE, 2025-2035 (USD Billion)
    83. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    84. | | 7.18.1 BY TYPE, 2025-2035 (USD Billion)
    85. | | 7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
    86. | | 7.18.3 BY MATERIAL, 2025-2035 (USD Billion)
    87. | | 7.18.4 BY END USE, 2025-2035 (USD Billion)
    88. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    89. | | 7.19.1 BY TYPE, 2025-2035 (USD Billion)
    90. | | 7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
    91. | | 7.19.3 BY MATERIAL, 2025-2035 (USD Billion)
    92. | | 7.19.4 BY END USE, 2025-2035 (USD Billion)
    93. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.20.1 BY TYPE, 2025-2035 (USD Billion)
    95. | | 7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
    96. | | 7.20.3 BY MATERIAL, 2025-2035 (USD Billion)
    97. | | 7.20.4 BY END USE, 2025-2035 (USD Billion)
    98. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    99. | | 7.21.1 BY TYPE, 2025-2035 (USD Billion)
    100. | | 7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
    101. | | 7.21.3 BY MATERIAL, 2025-2035 (USD Billion)
    102. | | 7.21.4 BY END USE, 2025-2035 (USD Billion)
    103. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    104. | | 7.22.1 BY TYPE, 2025-2035 (USD Billion)
    105. | | 7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
    106. | | 7.22.3 BY MATERIAL, 2025-2035 (USD Billion)
    107. | | 7.22.4 BY END USE, 2025-2035 (USD Billion)
    108. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    109. | | 7.23.1 BY TYPE, 2025-2035 (USD Billion)
    110. | | 7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
    111. | | 7.23.3 BY MATERIAL, 2025-2035 (USD Billion)
    112. | | 7.23.4 BY END USE, 2025-2035 (USD Billion)
    113. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    114. | | 7.24.1 BY TYPE, 2025-2035 (USD Billion)
    115. | | 7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
    116. | | 7.24.3 BY MATERIAL, 2025-2035 (USD Billion)
    117. | | 7.24.4 BY END USE, 2025-2035 (USD Billion)
    118. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    119. | | 7.25.1 BY TYPE, 2025-2035 (USD Billion)
    120. | | 7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
    121. | | 7.25.3 BY MATERIAL, 2025-2035 (USD Billion)
    122. | | 7.25.4 BY END USE, 2025-2035 (USD Billion)
    123. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.26.1 BY TYPE, 2025-2035 (USD Billion)
    125. | | 7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
    126. | | 7.26.3 BY MATERIAL, 2025-2035 (USD Billion)
    127. | | 7.26.4 BY END USE, 2025-2035 (USD Billion)
    128. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    129. | | 7.27.1 BY TYPE, 2025-2035 (USD Billion)
    130. | | 7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
    131. | | 7.27.3 BY MATERIAL, 2025-2035 (USD Billion)
    132. | | 7.27.4 BY END USE, 2025-2035 (USD Billion)
    133. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    134. | | 7.28.1 BY TYPE, 2025-2035 (USD Billion)
    135. | | 7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
    136. | | 7.28.3 BY MATERIAL, 2025-2035 (USD Billion)
    137. | | 7.28.4 BY END USE, 2025-2035 (USD Billion)
    138. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    139. | | 7.29.1 BY TYPE, 2025-2035 (USD Billion)
    140. | | 7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
    141. | | 7.29.3 BY MATERIAL, 2025-2035 (USD Billion)
    142. | | 7.29.4 BY END USE, 2025-2035 (USD Billion)
    143. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    144. | | 7.30.1 BY TYPE, 2025-2035 (USD Billion)
    145. | | 7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
    146. | | 7.30.3 BY MATERIAL, 2025-2035 (USD Billion)
    147. | | 7.30.4 BY END USE, 2025-2035 (USD Billion)
    148. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    149. | | 7.31.1
    150. | 7.32 ACQUISITION/PARTNERSHIP
    151. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Drug-Eluting Balloons
  • Plain Old Balloons
  • Scoring Balloons

Healthcare By Application (USD Billion, 2025-2035)

  • Coronary Angioplasty
  • Peripheral Angioplasty
  • Renal Angioplasty

Healthcare By Material (USD Billion, 2025-2035)

  • Polymer
  • Latex
  • Metal

Healthcare By End Use (USD Billion, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓